Valuation : Nephros, Inc.

Market Cap 44.53M 38.41M 36.13M 32.91M 61.89M 4.23B 62.23M 427M 166M 2.15B 167M 164M 7.13B P/E 2026 *
26.2x
P/E 2027 * 15.8x
Enterprise Value 44.53M 38.41M 36.13M 32.91M 61.89M 4.23B 62.23M 427M 166M 2.15B 167M 164M 7.13B EV / Sales 2026 *
2.01x
EV / Sales 2027 * 1.74x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
1 day+3.17%
1 week+4.44%
Current month-1.17%
1 month+20.51%
3 months+11.32%
6 months+3.68%
Current year-13.32%
1 week 4
Extreme 4.001
4.62
1 month 3.35
Extreme 3.35
4.87
Current year 2.66
Extreme 2.6629
5.46
1 year 2.66
Extreme 2.6629
6.42
3 years 1.35
Extreme 1.35
6.42
5 years 0.91
Extreme 0.9051
9.1
10 years 0
Extreme 0
11.67
Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 60 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 54 10/08/2018
Director/Board Member 58 08/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
12/08/26 Free

Director

2,418 0.0223%
23/03/26 Exercice

Chief Financial Officer

137,722 1.2960%
23/03/26 Exercice

Chief Executive Officer

240,000 2.2585%
Change 5-day change 1-year change 3-year change Capi.($)
+3.17%+4.44%+0.71%+166.04% 44.53M
+0.19%-10.35% - - 12.92B
+0.51%-5.77%+12.65%+41.77% 10.4B
+1.08%+0.36%+55.05%+409.97% 4.13B
-4.03%-6.90%+13.65%+206.88% 3.74B
-3.11%-0.08%+35.42%+78.80% 1.32B
+0.60%+3.19% - - 1.12B
+1.44%+8.97%+201.18%+243.48% 933M
-3.65%-3.93%+139.54%+141.69% 931M
+0.24%+4.89%+141.89%+158.95% 880M
Average -0.39%-0.70%+75.01%+180.95% 3.64B
Weighted average by Cap. -0.34%-3.44%+40.18%+156.92%

Financials

2026 *2027 *
Net sales 22.14M 19.09M 17.96M 16.36M 30.77M 2.1B 30.94M 212M 82.64M 1.07B 83.11M 81.31M 3.54B 25.66M 22.13M 20.82M 18.96M 35.66M 2.43B 35.86M 246M 95.79M 1.24B 96.32M 94.24M 4.11B
Net income 1.76M 1.52M 1.43M 1.3M 2.45M 167M 2.47M 16.92M 6.59M 85.18M 6.62M 6.48M 282M 2.92M 2.52M 2.37M 2.16M 4.05M 277M 4.08M 27.97M 10.89M 141M 10.95M 10.71M 467M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
36
Date Price Change Volume
02/09/26 $4.230 +3.17% 2,129
01/09/26 $4.100 -4.21% 21,634
31/08/26 $4.280 -5.93% 37,698
28/08/26 $4.550 +5.57% 21,358
27/08/26 $4.310 +6.42% 12,118
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.100USD
Average target price
6.250USD
Spread / Average Target
+52.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEPH Stock